INCREASED TESTICULAR CD2+ & INFERTILITY WITH VARICOCELE

睾丸 CD2 增加

基本信息

项目摘要

DESCRIPTION: Varicocele-associated human male infertility (VAI) represents greater then 20 percent of male infertility in the US. Surgical repair of varicocele restores fertility only 1/3 of time. Identification of VAI likely to benefit from surgical correction offers health cost savings. In preliminary studies, VAI patients' seminal plasma and testes biopsies contain significantly higher cadmium (Cd2+) than other infertile males, though blood levels were indistinguishable. VAI sperm lose normal sperm surface proteins binding actin, including mannose and progesterone receptors, and normal sperm head cytoskeletal structures. In vitro incubation of fertile human sperm in Cd2+ containing media replicate VAI cytoskeletal defects. Autometallographic imaging of biopsies confirmed high Cd2+ in VAI testes. Probing serial testes sections revealed decreased actin expression with differentiation stage, and increased frequency of apoptotic nuclei in VAI tubules. Sperm voltage-dependent calcium channels (VDCC) are an apparent entry point for Cd2+ VDCC isoform expression variability correlates with mannose receptor function. VAI patient partners became pregnant within three years only if surgical correction restored normal mannose receptor function. Therefore Cd2+ may be a cofactor with heat in producing VAI. In an expanded prospective study we will determine if seminal Cd2+ correlates with testicular Cd2+, and if seminal Cd2+, testicular Cd2+ and scrotal temperature are biomarkers for VAI reversal assessed by pregnancy and birth, taking one testicular biopsy and duplicate semen samples before and 3 months after correction. Intermediate endpoints for characterizing VAI will include: seminal plasma and testicular Zn2+, testicular Cd2+ and Zn2+ distributions by autometallography, sperm response to capacitating incubation (mannose receptor assay) and to acrosome-reaction induction by polvalent mannose, assessment of actin distributions, levels of apoptosis and VDCC expression. Controls will include men from couples undergoing IVF/ICSI for non-obstructive azoospermia and males with primary VAI who refuse correction. To further characterize VAI, abnormalities in intermediate endpoints among individuals (e.g. apoptosis and actin loss) will be correlated with changes in VDCC primary structure in regions afecting metal ion sensitivity, channel gating potential and Ca2+ channel blocker binding as assesed from VDCC mRNA present in mature sperm, and with changes in a region of VDCC channel precursor sensitive to mannose-induced proteolysis, assessed by Western blot of sperm membrane proteins. Controls will include fertile donors and fertile men with varicocele.
描述:精索静脉曲张相关的人类男性不育症(VAI)代表 超过20%的美国男性不育。手术修复 精索静脉曲张恢复生育能力的时间只有1/3。确定可能 从手术矫正中获益可节省医疗费用。初步 研究表明,VAI患者的精浆和睾丸活检中含有显著的 高镉(Cd 2+)比其他不育男性,虽然血液水平 无法区分VAI精子失去了正常的精子表面蛋白结合肌动蛋白, 包括甘露糖和孕酮受体,以及正常的精子头 细胞骨架结构人生育精子在Cd ~(2+)中的体外孵育 含有培养基复制VAI细胞骨架缺陷。自显影成像 的活组织检查证实VAI睾丸中存在高Cd 2+。探测连续睾丸切片 肌动蛋白表达随着分化阶段的增加而降低, VAI小管中凋亡核的频率。精子电压依赖性钙 通道(VDCC)是Cd 2 + VDCC亚型表达的明显切入点 变异性与甘露糖受体功能相关。奥钢联患者合作伙伴 只有手术矫正恢复正常才能在三年内怀孕 甘露糖受体功能因此,Cd 2+可能是一个辅因子与热在 生产VAI。在一项扩大的前瞻性研究中,我们将确定 Cd ~(2+)与睾丸Cd ~(2+)相关,如果精液Cd ~(2+)、睾丸Cd ~(2+)和 阴囊温度是通过妊娠评估VAI逆转的生物标志物, 分娩前和分娩后3个月, 纠正后的几个月。表征VAI的中间终点将 包括精浆和睾丸Zn ~(2+),睾丸Cd ~(2+)和Zn ~(2 + 精子分布(自动记录法),精子对获能孵育的反应 (甘露糖受体测定)和顶体反应诱导的多价 甘露糖,肌动蛋白分布评估,凋亡水平和VDCC 表情对照将包括来自接受IVF/ICSI的夫妇的男性, 非梗阻性无精子症和拒绝矫正的原发性VAI男性。 为了进一步表征VAI, 个体(例如细胞凋亡和肌动蛋白损失)将与 影响金属离子灵敏度的区域中的VDCC一级结构,通道 根据VDCC mRNA评估的门控电位和Ca 2+通道阻滞剂结合 存在于成熟精子中,并且VDCC通道前体区域发生变化 对甘露糖诱导的蛋白水解敏感,通过精子的Western印迹评估 膜蛋白对照将包括有生育能力的供体和有生育能力的男性, 精索静脉曲张

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUSAN H BENOFF其他文献

SUSAN H BENOFF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUSAN H BENOFF', 18)}}的其他基金

Annual SMRU Traveling Scholars Conference
年度 SMRU 旅行学者会议
  • 批准号:
    7161502
  • 财政年份:
    2006
  • 资助金额:
    $ 30.34万
  • 项目类别:
Annual SMRU Traveling Scholar Conference
年度 SMRU 旅行学者会议
  • 批准号:
    7000854
  • 财政年份:
    2005
  • 资助金额:
    $ 30.34万
  • 项目类别:
Annual SMRU Traveling Scholar Conference
年度 SMRU 旅行学者会议
  • 批准号:
    6887862
  • 财政年份:
    2004
  • 资助金额:
    $ 30.34万
  • 项目类别:
Annual SMRU Traveling Scholar Conference
年度 SMRU 旅行学者会议
  • 批准号:
    6711534
  • 财政年份:
    2002
  • 资助金额:
    $ 30.34万
  • 项目类别:
INCREASED TESTICULAR CD2+ & INFERTILITY WITH VARICOCELE
睾丸 CD2 增加
  • 批准号:
    6087219
  • 财政年份:
    2000
  • 资助金额:
    $ 30.34万
  • 项目类别:
Male Subfertility By Ni2+ Poisoning of Ca2+ Channels ?
Ca2 通道 Ni2 中毒导致男性生育力低下?
  • 批准号:
    6314846
  • 财政年份:
    2000
  • 资助金额:
    $ 30.34万
  • 项目类别:
Male Subfertility By Ni2+ Poisoning of Ca2+ Channels ?
Ca2 通道 Ni2 中毒导致男性生育力低下?
  • 批准号:
    6446074
  • 财政年份:
    2000
  • 资助金额:
    $ 30.34万
  • 项目类别:
INCREASED TESTICULAR CD2+ & INFERTILITY WITH VARICOCELE
睾丸 CD2 增加
  • 批准号:
    6518182
  • 财政年份:
    2000
  • 资助金额:
    $ 30.34万
  • 项目类别:
INCREASED TESTICULAR CD2+ & INFERTILITY WITH VARICOCELE
睾丸 CD2 增加
  • 批准号:
    6743093
  • 财政年份:
    2000
  • 资助金额:
    $ 30.34万
  • 项目类别:
INCREASED TESTICULAR CD2+ & INFERTILITY WITH VARICOCELE
睾丸 CD2 增加
  • 批准号:
    6382367
  • 财政年份:
    2000
  • 资助金额:
    $ 30.34万
  • 项目类别:

相似海外基金

卵巣癌/子宮体癌における薬剤感受性メチル化診断キットの開発とLiquid Biopsyへの応用
卵巢癌/子宫内膜癌药物敏感甲基化诊断试剂盒的研制及其在液体活检中的应用
  • 批准号:
    24K02584
  • 财政年份:
    2024
  • 资助金额:
    $ 30.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
グリオーマのliquid biopsyによるメチル化網羅的解析とprecision medicineへの応用
胶质瘤液体活检甲基化综合分析及其在精准医疗中的应用
  • 批准号:
    24K12271
  • 财政年份:
    2024
  • 资助金额:
    $ 30.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis (MONALISA)
SIOPEN 通过液体活检敏感性分析 (MONALISA) 监测神经母细胞瘤复发的实用临床试验
  • 批准号:
    10110442
  • 财政年份:
    2024
  • 资助金额:
    $ 30.34万
  • 项目类别:
    EU-Funded
MONALISA: A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
MONALISA:一项 SIOPEN 实用临床试验,通过液体活检监测神经母细胞瘤复发 敏感性分析
  • 批准号:
    10103126
  • 财政年份:
    2024
  • 资助金额:
    $ 30.34万
  • 项目类别:
    EU-Funded
精神的長期ストレス児童の口腔細菌叢と唾液成分の解析:唾液 liquid biopsyを目指して
长期精神应激儿童口腔菌群和唾液成分分析:唾液液体活检
  • 批准号:
    24K13206
  • 财政年份:
    2024
  • 资助金额:
    $ 30.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Liquid biopsyを用いた炎症性腸疾患の早期診断法開発
液体活检炎症性肠病早期诊断方法的开发
  • 批准号:
    24K10595
  • 财政年份:
    2024
  • 资助金额:
    $ 30.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mutated human oncogene recombinant nucleosomes as reference materials for liquid biopsy
突变人癌基因重组核小体作为液体活检参考材料
  • 批准号:
    10090714
  • 财政年份:
    2024
  • 资助金额:
    $ 30.34万
  • 项目类别:
    Collaborative R&D
肝細胞癌における術中門脈血を用いたliquid biopsyの検討
肝细胞癌术中门静脉血液体活检检查
  • 批准号:
    24K19404
  • 财政年份:
    2024
  • 资助金额:
    $ 30.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Genetic diagnosis of vascular malformations by liquid biopsy and its application to precision medicine
液体活检对血管畸形的基因诊断及其在精准医疗中的应用
  • 批准号:
    23K09072
  • 财政年份:
    2023
  • 资助金额:
    $ 30.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Breath biopsy technology targeting for volatile oxidized lipids
针对挥发性氧化脂质的呼吸活检技术
  • 批准号:
    23K06080
  • 财政年份:
    2023
  • 资助金额:
    $ 30.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了